Yang Zhi-Zhang, Novak Anne J, Ziesmer Steven C, Witzig Thomas E, Ansell Stephen M
Division of Hematology and Internal Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Cancer Res. 2006 Oct 15;66(20):10145-52. doi: 10.1158/0008-5472.CAN-06-1822.
The underlying mechanisms by which tumor cells are resistant to CTL-mediated apoptosis are not clear. Using a human model of B-cell non-Hodgkin's lymphoma (B-cell NHL), we show that intratumoral T(reg) cells inhibit the proliferation and granule production of activated autologous infiltrating CD8(+) T cells. Our results also show that degranulation and subsequent cytotoxic activity of infiltrating CD8(+) T cells exposed to lymphoma B cells is completely attenuated by the presence of intratumoral T(reg) cells. Furthermore, we show that increased numbers of intratumoral T(reg) cells correlates with the number of CD8(+) T cells in biopsy specimens from patients with B-cell NHL, supporting the in vitro findings that intratumoral T(reg) cells inhibit proliferation of infiltrating CD8(+) T cells. Taken together, these data indicate that human lymphoma B cells are sensitive to autologous CTL-mediated cell death but are protected by the inhibitory function of intratumoral T(reg) cells.
肿瘤细胞对细胞毒性T淋巴细胞(CTL)介导的细胞凋亡产生抗性的潜在机制尚不清楚。利用B细胞非霍奇金淋巴瘤(B细胞NHL)的人类模型,我们发现肿瘤内调节性T(Treg)细胞抑制活化的自体浸润性CD8+T细胞的增殖和颗粒产生。我们的结果还表明,肿瘤内Treg细胞的存在会完全减弱浸润性CD8+T细胞与淋巴瘤B细胞接触后的脱颗粒及随后的细胞毒性活性。此外,我们发现肿瘤内Treg细胞数量的增加与B细胞NHL患者活检标本中CD8+T细胞的数量相关,这支持了肿瘤内Treg细胞抑制浸润性CD8+T细胞增殖的体外研究结果。综上所述,这些数据表明人类淋巴瘤B细胞对自体CTL介导的细胞死亡敏感,但受到肿瘤内Treg细胞抑制功能的保护。